If you are currently looking into stocks that recorded significant gains last week, then it is likely that you might have come across the Northwest Biotherapeutics (OTC: NWBO) stock.
The Northwest stock soared by as high as 12% on Friday but there was no news about the company that might have triggered the jump. The last significant development with regards to the company came about back in January this year when Northwest announced its financial results for the third quarter of 2020.
In the third quarter, Northwest suffered a loss of as huge as $194 million or 7 cents a share post adjustments. At the same time, the revenues for the period stood at $216,000. The company’s performance in the quarter was clearly a bit of a disappointment but at the same time, investors need to note that the stock has grown considerably since last year. In January of 2020, the stock was changing hands for only 21 cents each.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.